000			01643 a2200445 4500
005			20250513100346.0
264		0	_c19961107
008			199611s 0 0 eng d
022			_a0192-0561
024	7		_a10.1016/0192-0561(96)00002-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aD'Agostini, C
245	0	0	_aEfficacy of combination therapy with amantadine, thymosin alpha 1 and alpha/beta interferon in mice infected with influenza A virus. _h[electronic resource]
260			_bInternational journal of immunopharmacology _cFeb 1996
300			_a95-102 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmantadine _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aCell Count _xdrug effects
650	0	4	_aDrug Therapy, Combination
650	0	4	_aInfluenza A virus
650	0	4	_aInterferon Type I _xtherapeutic use
650	0	4	_aKiller Cells, Natural _xphysiology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aOrthomyxoviridae Infections _xdrug therapy
650	0	4	_aT-Lymphocyte Subsets _xdrug effects
650	0	4	_aT-Lymphocytes, Cytotoxic _xcytology
650	0	4	_aThymosin _xtherapeutic use
700	1		_aPalamara, A T
700	1		_aFavalli, C
700	1		_aSivilia, M
700	1		_aFebbraro, G
700	1		_aBue, C
700	1		_aGaraci, E
773	0		_tInternational journal of immunopharmacology _gvol. 18 _gno. 2 _gp. 95-102
856	4	0	_uhttps://doi.org/10.1016/0192-0561(96)00002-1 _zAvailable from publisher's website
999			_c8795653 _d8795653